Antibiotic cost-containment
- PMID: 3743415
- DOI: 10.1177/106002808602000718
Antibiotic cost-containment
Abstract
A multidisciplinary, professional, and administrative approach to selecting therapeutic agents for formulary inclusion--as it is practiced at the Tuskegee Veterans Administration Medical Center--is described. The process by which members of a Drug Utilization Review Subcommittee evaluate drugs is explained in detail. Numerous factors, such as patient population characteristics, total therapy costs, adverse reactions, indications, dosage, and efficacy are considered. Findings, decisions, and economic cost-savings, specifically with respect to antibiotics, are revealed.
Similar articles
-
A multidisciplinary process to determine, communicate, and manage an antibiotic formulary.Hosp Pharm. 1992 Oct;27(10):867-9, 872-4, 882. Hosp Pharm. 1992. PMID: 10121423
-
Cost containment through P & T committee drug utilization review.Hosp Formul. 1984 Aug;19(8):699-700, 705-7. Hosp Formul. 1984. PMID: 10267391
-
An approach to cost-effective antibiotic utilization.Hosp Formul. 1988 Dec;23 Suppl D:32-5. Hosp Formul. 1988. PMID: 10312796
-
Containing costs of antimicrobials in the hospital: a critical evaluation.Am J Infect Control. 1989 Oct;17(5):300-10. doi: 10.1016/0196-6553(89)90187-9. Am J Infect Control. 1989. PMID: 2683889 Review.
-
Controlling financial variables--changing prescribing patterns.Am J Hosp Pharm. 1984 Mar;41(3):503-15. Am J Hosp Pharm. 1984. PMID: 6367444 Review.
Cited by
-
Ceftriaxone. A pharmacoeconomic evaluation of its use in the treatment of serious infections.Pharmacoeconomics. 1994 Sep;6(3):249-69. doi: 10.2165/00019053-199406030-00009. Pharmacoeconomics. 1994. PMID: 10155268
MeSH terms
Substances
LinkOut - more resources
Medical